SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-141608
Filing Date
2021-04-30
Accepted
2021-04-29 21:06:00
Documents
2
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d176237ddef14a.htm DEF 14A 621216
2 GRAPHIC g176237g28v18.jpg GRAPHIC 70468
  Complete submission text file 0001193125-21-141608.txt   713375
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36783 | Film No.: 21873281
SIC: 2834 Pharmaceutical Preparations